Lupin pledges Rs21 cr towards COVID-19 relief efforts

The Coronavirus pandemic and the concern related to the extent of damage it can cause had brought in a good degree of participation form major corporations, philanthropists, and business leaders to support the fight against the pandemic.

Pharma major Lupin Limited (Lupin) announced a contribution of Rs 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin’s Global Giving Program comprises of three separate contributions made by its employees, the Company and the promoter family, as per the press release.

Lupin’s employees have contributed generously by giving two days of their individual salaries, together contributing a sum of Rs 5.5 crores to the Prime Minister’s Citizen Assistance and Relief in Emergency Situations Fund (PM CARES Fund). Lupin has matched an equal sum of Rs 5.5 crores for direct initiatives that the company will implement to support overburdened national and state healthcare systems through donation of personal protective equipment, medicines and providing meals for front-line workers and the needy.

In addition, the promoter Desh Bandhu Gupta family has committed a sum of Rs10 crores for other direct impact initiatives in India and elsewhere in the world to supplement Lupin’s relief efforts to tackle the COVID-19 crisis.

Nilesh Gupta, Managing Director, Lupin said, “We commend the Central and State governments in India and other authorities globally for taking proactive measures to control the spread of the coronavirus. As one of the leading pharmaceutical companies globally, Lupin remains committed to ensure uninterrupted supply of medicines across India and global markets while ensuring safety of our personnel involved. We are grateful for this opportunity to support those who are at the front-line of this battle against COVID-19.”

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products and APIs in over 100 markets in the U.S., India, South Africa and across Asia Pacific (APAC), Latin America (LATAM), Europe and Middle-East regions.

Website | + posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: